Scott B. Ullem - 16 Feb 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Chief Financial Officer
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 16 Feb 2023
Transactions value $: $0
Form type: 4
Filing time: 17 Feb 2023, 17:34:40 UTC
Previous filing: 13 Feb 2023
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+1.94K	+12%	$0.00	18.1K	16 Feb 2023	Direct	F1
holding	EW	Common Stock						258K	16 Feb 2023	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on February 16, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.